157
Views
15
CrossRef citations to date
0
Altmetric
Pigmentary disorders

Periocular lentigo maligna treated with imiquimod

, &
Pages 109-112 | Received 11 Nov 2009, Accepted 09 Dec 2009, Published online: 28 Jul 2010

References

  • Leppala J, Kaarniranta K, Uusitalo H, Kontkanen M. Imiquimod in the treatment of eyelid basal cell carcinoma. Acta Ophthalmol Scand. 2007;85:566–568.
  • Chootanom R, Thanos S, Busse H, Stupp T. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: A 3 year follow up study. Graefes Arch Clin Exp Ophthalmol. 2007;245:1217–1220.
  • Brannan PA, Anderson HK, Kersten RC, Kulwin DR. Bowen disease of the eyelid successfully treated with imiquimod. Ophthal Plast Reconstr Surg. 2005;21(4):321–322.
  • Murchison AP, Washington CV, Soloman AR, Bernardino CR. Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatol Surg. 2007;33:1136–1138.
  • Buettiker UV, Yawalkar NY, Braathen LR, Hunger RE. Imiquimod treatment of lentigo maligna: An open-label study of 34 primary lesions in 32 patients. Arch Dermatol. 2008;144(7):943–945.
  • Mahoney MH, Joseph MG, Temple C. Topical imiquimod therapy for lentigo maligna. Ann Plast Surg. 2008;61(4):419–423.
  • Rajpar SF, Marsden JR. Imiquimod in the treatment of lentigo maligna. Br J Dermatol. 2006;155:653–656.
  • Fisher GH, Lang PG. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Arch Dermatol. 2003;139(7):945–947.
  • Naylor MF, Crowson N, Kuwahara R, Teague K, Garcia C, Mackinnis C, Treatment of lentigo maligna with topical imiquimod. Br J Dermatol. 2003;149(suppl 66):66–70.
  • Van Meurs T, Van Doorn R, Kirtschig G. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. Dermatol Surg. 2007;33:623–627.
  • Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108–1114.
  • Chalasani R, Giblin M, Conway RM. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: Review of the evidence and recommendations for treatment. Clin Experiment Ophthalmol. 2006;34(7):708–714.
  • Finger PT, Sedeek RW, Chin KJ. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol. 2008;145(1):124–129.
  • Stannard CE, Sealy GR, Hering ER, Pereira SB, Knowles R, Hill JC. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology. 2000;107(5):951–958.
  • Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP, Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol. 2006;244(4):438–446.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.